UBS Group’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.28K | Buy |
+6,074
| New | +$5.28K | ﹤0.01% | 7865 |
|
|
2025
Q1 | – | Sell |
-116
| Closed | -$244 | – | 9089 |
|
|
2024
Q4 | $244 | Buy |
+116
| New | +$244 | ﹤0.01% | 8305 |
|
|
2024
Q1 | – | Sell |
-4,532
| Closed | -$5.67K | – | 8410 |
|
|
2023
Q4 | $5.67K | Buy |
+4,532
| New | +$5.67K | ﹤0.01% | 6561 |
|
|
2023
Q3 | – | Sell |
-99
| Closed | -$72 | – | 8512 |
|
|
2023
Q2 | $72 | Sell |
99
-4,540
| -98% | -$3.3K | ﹤0.01% | 7471 |
|
|
2023
Q1 | $12.6K | Sell |
4,639
-957
| -17% | -$2.6K | ﹤0.01% | 6341 |
|
|
2022
Q4 | $13.8K | Sell |
5,596
-802
| -13% | -$1.97K | ﹤0.01% | 6953 |
|
|
2022
Q3 | $16K | Buy |
6,398
+2,227
| +53% | +$5.57K | ﹤0.01% | 6596 |
|
|
2022
Q2 | $12K | Buy |
4,171
+1,508
| +57% | +$4.34K | ﹤0.01% | 6627 |
|
|
2022
Q1 | $9K | Sell |
2,663
-1,471
| -36% | -$4.97K | ﹤0.01% | 7499 |
|
|
2021
Q4 | $17K | Buy |
+4,134
| New | +$17K | ﹤0.01% | 6947 |
|